Botea F, Braşoveanu V, Constantinescu A, Ionescu Mi, Matei E, Popescu I
Fundeni Clinical Institute, Bucharest, Romania.
Chirurgia (Bucur). 2013 Jul-Aug;108(4):547-52.
Living donor liver transplantation (LDLT) exposes to risks both the donor, due to a potential small residual liver volume, and the recipient, who faces the risk of small-for-size graft syndrome. In order to overcome these drawbacks, liver grafts from two different donors can be used. This paper presents a case of dual graft LDLT using a right hemiliver and a left lateral section from related donors.
A 14-year old female diagnosed with chronic hepatic failure due to Wilson's disease with Model-for-End- Stage-Liver-Disease score of 25, underwent a dual graft LDLT, receiving a right hemiliver with a reconstructed middle hepatic vein from her sister, and a left lateral section from her mother. None of the grafts complied with a satisfactory graft-to-recipient weight ratio (GRWR), if they would have been independently transplanted. The combined GRWR was 1.10. The donors and the recipient have been followed-up for over 1 year.
The donors had no postoperative complications. The donors and the recipient were discharged 8 and 19 days after surgery, respectively. After 12-month follow-up, both donors and the recipient were alive, with normal graft function.
Dual graft LDLT can be a feasible solution to overcome the risk of small-for-size graft syndrome.
BSA = body surface area, GRWR = graft-to-recipient weight ratio, GV SLV = recipient standard liver volume, HA = hepatic artery, HD = hepatic duct, HV = hepatic vein, LDLT = Living donor liver transplantation, LL = left lobe, LLS = left lateral section, MELD = Model for End-Stage Liver Disease, POD = postoperative day, PV = portal vein, RL = right lobe, SFS = small-for-size graft, SLV = standard liver volume, WD = Wilson's disease.
活体肝移植(LDLT)对供体和受体均有风险,供体存在潜在小肝残余体积风险,受体则面临小体积移植物综合征风险。为克服这些缺点,可使用来自两个不同供体的肝移植物。本文介绍了一例使用相关供体的右半肝和左外叶进行双移植物LDLT的病例。
一名14岁女性因威尔逊病被诊断为慢性肝衰竭,终末期肝病模型评分25分,接受了双移植物LDLT,从其姐姐处获得带有重建肝中静脉的右半肝,从其母亲处获得左外叶。如果单独移植,这些移植物均未达到令人满意的移植物与受体重量比(GRWR)。联合GRWR为1.10。对供体和受体进行了超过1年的随访。
供体无术后并发症。供体和受体分别在术后8天和19天出院。经过12个月的随访,供体和受体均存活,移植物功能正常。
双移植物LDLT可能是克服小体积移植物综合征风险的可行解决方案。
BSA = 体表面积,GRWR = 移植物与受体重量比,GV SLV = 受体标准肝体积,HA = 肝动脉,HD = 肝管,HV = 肝静脉,LDLT = 活体肝移植,LL = 左叶,LLS = 左外叶,MELD = 终末期肝病模型,POD = 术后天数,PV = 门静脉,RL = 右叶,SFS = 小体积移植物,SLV = 标准肝体积,WD = 威尔逊病